Convalescent plasma and COVID-19: Time for a second—second look?

Michael J. Joyner; Rickey E. Carter; De Lisa Fairweather; R. Scott Wright

doi:10.1111/tme.12915

Convalescent plasma and COVID-19: Time for a second—second look?

Michael J. Joyner, Rickey E. Carter, De Lisa Fairweather, R. Scott Wright

Research output: Contribution to journal › Review article › peer-review

Abstract

In this short narrative, we highlight some of our experiences leading the US Convalescent Plasma Program at the beginning of the pandemic in the spring and summer of 2020. This includes a brief summary of how the program emerged and high-level lessons we learned. We also share our impressions about why convalescent plasma was used at scale in the United States, early in the pandemic and share ideas that might inform the use of convalescent plasma in future outbreaks of novel infectious diseases.

Original language	English (US)
Pages (from-to)	16-20
Number of pages	5
Journal	Transfusion Medicine
Volume	33
Issue number	1
DOIs	https://doi.org/10.1111/tme.12915
State	Published - Feb 2023

Keywords

convalescent plasma
pandemic preparedness
real-world evidence

ASJC Scopus subject areas

Hematology

Access to Document

10.1111/tme.12915

Cite this

@article{db4d6cecf03742678f503a6cb5fbd1d2,

title = "Convalescent plasma and COVID-19: Time for a second—second look?",

abstract = "In this short narrative, we highlight some of our experiences leading the US Convalescent Plasma Program at the beginning of the pandemic in the spring and summer of 2020. This includes a brief summary of how the program emerged and high-level lessons we learned. We also share our impressions about why convalescent plasma was used at scale in the United States, early in the pandemic and share ideas that might inform the use of convalescent plasma in future outbreaks of novel infectious diseases.",

keywords = "convalescent plasma, pandemic preparedness, real-world evidence",

author = "Joyner, {Michael J.} and Carter, {Rickey E.} and Fairweather, {De Lisa} and Wright, {R. Scott}",

note = "Publisher Copyright: {\textcopyright} 2022 British Blood Transfusion Society.",

year = "2023",

month = feb,

doi = "10.1111/tme.12915",

language = "English (US)",

volume = "33",

pages = "16--20",

journal = "Transfusion Medicine",

issn = "0958-7578",

publisher = "Wiley-Blackwell",

number = "1",

}

TY - JOUR

T1 - Convalescent plasma and COVID-19

T2 - Time for a second—second look?

AU - Joyner, Michael J.

AU - Carter, Rickey E.

AU - Fairweather, De Lisa

AU - Wright, R. Scott

PY - 2023/2

Y1 - 2023/2

N2 - In this short narrative, we highlight some of our experiences leading the US Convalescent Plasma Program at the beginning of the pandemic in the spring and summer of 2020. This includes a brief summary of how the program emerged and high-level lessons we learned. We also share our impressions about why convalescent plasma was used at scale in the United States, early in the pandemic and share ideas that might inform the use of convalescent plasma in future outbreaks of novel infectious diseases.

AB - In this short narrative, we highlight some of our experiences leading the US Convalescent Plasma Program at the beginning of the pandemic in the spring and summer of 2020. This includes a brief summary of how the program emerged and high-level lessons we learned. We also share our impressions about why convalescent plasma was used at scale in the United States, early in the pandemic and share ideas that might inform the use of convalescent plasma in future outbreaks of novel infectious diseases.

KW - convalescent plasma

KW - pandemic preparedness

KW - real-world evidence

UR - http://www.scopus.com/inward/record.url?scp=85137778690&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85137778690&partnerID=8YFLogxK

U2 - 10.1111/tme.12915

DO - 10.1111/tme.12915

M3 - Review article

C2 - 36089562

AN - SCOPUS:85137778690

SN - 0958-7578

VL - 33

SP - 16

EP - 20

JO - Transfusion Medicine

JF - Transfusion Medicine

IS - 1

ER -

Convalescent plasma and COVID-19: Time for a second—second look?

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this